Archive · 2 Aug 2025
SpaceX Launches Bacteria to Space for Disease Research
NASA sent bacteria to the International Space Station (ISS) with the Crew-11 mission.
These bacteria can cause diseases.
Scientists want to see how space affects them.
They'll study the bacteria and viruses that kill them.
The goal is to learn how to stop bacteria from resisting antibiotics.
They also hope to find new ways to treat infections, in space and on Earth.
The experiment could help scientists understand how diseases spread and how to fight them.
It is a big step towards healthier space missions and maybe even a future without some antibiotics.
NASA's Crew-11 mission launched bacteria strains, including E. coli and Salmonella, to the ISS.
The study aims to understand how microgravity affects bacteria and bacteriophages (viruses that kill bacteria).
Researchers will analyze how space conditions impact gene expression related to virulence and antibiotic resistance.
The experiment could potentially reduce reliance on antibiotics by using bacteriophages to treat infections.
Scientists hope to gain insights to combat infectious diseases and antibiotic resistance both in space and on Earth.
- Who
- NASA, SpaceX, Sheba Medical Center, Boeing and scientists are involved.
- What
- A study on the effects of microgravity on bacteria and bacteriophages was launched to the ISS.
- When
- The study was launched on Friday, August 1, aboard the Crew-11 mission.
- Where
- The study is taking place on the International Space Station (ISS).
- Why
- To understand how microgravity affects bacteria, and to explore potential ways to combat infectious diseases and antibiotic resistance.
- Mission
- Crew-11
- Bacteria types
- E. coli, Salmonella bongori, Salmonella typhimurium
- Objective
- Study bacterial behavior in microgravity
- Method
- Analyze gene expression and growth
- Partners
- SpaceTango, Boeing
- Experiment Name
- Genes in Space-12